Aethlon Medical Corp (AEMD) - Kapitalisasi marang bathi

Aethlon Medical (AEMD) adheres to RoHS environmental standards during the production of its filtration systems, monitoring the disposal of industrial waste. The company possesses significant pricing power within its niche due to its unique mechanism for clearing exosomes and viruses from the blood. This price chart featuring the -1.30 metric clearly visualizes the market dynamics. The company's revenues are based on the sale of patented cartridges for combating oncology and infections.

Investors utilize multiples to determine whether an asset is overbought relative to its fundamental value. This metric is calculated by dividing market capitalization by net income, measuring the payback period of the investment. For Aethlon Medical (AEMD), high R&D costs and dependence on clinical trials make this calculation extremely volatile. A critical lack of liquidity amplifies risks during any deviations. The company's price-to-earnings ratio clearly demonstrates the danger of excessive market optimism.